⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OTLK News
Outlook Therapeutics, Inc. Common Stock
Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
globenewswire.com
OTLK
Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010
globenewswire.com
OTLK
Outlook Therapeutics Provides Update on Type A Meeting with FDA
globenewswire.com
OTLK